Paid Clinical Trials in Fort Worth, TX

As of July 2026, 327 paid clinical trials are recruiting in Fort Worth, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

299 clinical trials

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for Type 1 Diabetes

Sites in Fort Worth, Dallas +21 more locations

Sponsor: SAb Biotherapeutics, Inc.

Sex: All·Age: 5 - 40

Code: NCT07187531·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

for Eosinophilic Esophagitis (EoE)

Drug: Dupilumab

Sites in Fort Worth +10 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 6 Months - 6

Code: NCT07112378·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

A Study of PHST001 in Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Fort Worth, Irving +18 more locations

Sponsor: Pheast Therapeutics

Sex: All·Age: 18+

Code: NCT06840886·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

for Psoriatic Arthritis

Drug: Zasocitinib

Sites in Fort Worth, The Woodlands +19 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06671496·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

for Metastatic Breast Cancer

Sites in Fort Worth, The Woodlands +14 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT05894239·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Fort Worth, San Antonio +13 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06997029·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

for Dravet Syndrome

Sites in Fort Worth, Austin +20 more locations

Sponsor: Longboard Pharmaceuticals

Sex: All·Age: 2 - 65

Code: NCT06660394·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

for Neutropenia

Sites in Fort Worth, Dallas +20 more locations

Sponsor: X4 Pharmaceuticals

Sex: All·Age: 12+

Code: NCT06056297·Phase 3·Recruiting·Listed Sep 2023

Apply to this trial

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

for Muscular Atrophy, Spinal

Sites in Fort Worth, Dallas +9 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 3 Months - 24 Months

Code: NCT05861986·Phase 4·Recruiting·Listed May 2023

Apply to this trial

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Guselkumab

Sites in Fort Worth +11 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 2 - 17

Code: NCT05923073·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

for Dravet Syndrome

Sites in Fort Worth +10 more locations

Sponsor: Encoded Therapeutics

Sex: All·Age: 6 Months - 17

Code: NCT05419492·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

AcoArt Litos PCB Below-the-knee Global Trial

for Chronic Limb-Threatening Ischemia

Sites in Fort Worth, Dallas +13 more locations

Sponsor: Acotec Scientific Co., Ltd

Sex: All·Age: 18+

Code: NCT06330493·Recruiting·Listed Mar 2024

Apply to this trial

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

for Ulcerative Colitis

Sites in Fort Worth +10 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 2 - 19

Code: NCT04844606·Phase 3·Recruiting·Listed Apr 2021

Apply to this trial

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

for HR+/HER2- Breast Cancer

Sites in Fort Worth, Houston +13 more locations

Sponsor: Avenzo Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06998407·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for Crohn's Disease

Sites in Fort Worth +14 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 2 - 17

Code: NCT05509777·Phase 3·Recruiting·Listed Aug 2022

Apply to this trial

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

for Spinal Muscular Atrophy

Drug: Apitegromab

Sites in Fort Worth, Flower Mound +12 more locations

Sponsor: Scholar Rock, Inc.

Sex: All·Age: Up to 2

Code: NCT07047144·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

WRAP North America

for Venous Stenosis

Sites in Fort Worth, Humble +13 more locations

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT06807099·Recruiting·Listed Feb 2025

Apply to this trial

A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months

for Hypochondroplasia

Drug: Vosoritide

Sites in Fort Worth +9 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: 0 Months - 36 Months

Code: NCT07126262·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia

for Hypoxic-Ischemic Encephalopathy

Sites in Fort Worth +13 more locations

Sponsor: ReAlta Life Sciences, Inc.

Sex: All·Age: Up to 10 Hours

Code: NCT05778188·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

for Non-muscle-invasive Bladder Cancer

Sites in Fort Worth, Dallas +17 more locations

Sponsor: SURGE Therapeutics

Sex: All·Age: 18+

Code: NCT05710848·Phase 1, Phase 2·Recruiting·Listed Feb 2023

Apply to this trial

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

for Gastric Adenocarcinoma

Sites in Fort Worth, Bedford +12 more locations

Sponsor: Toray Industries, Inc

Sex: All·Age: 18+

Code: NCT06038578·Phase 2·Recruiting·Listed Sep 2023

Apply to this trial

AngelMed Guardian® System PMA Post Approval Study

for Acute Coronary Syndrome

Sites in Fort Worth, El Paso +10 more locations

Sponsor: Angel Medical Systems

Sex: All·Age: 21+

Code: NCT05412927·Recruiting·Listed Jun 2022

Apply to this trial

Clinical Data Registry of Amblyopia Patients on Luminopia Treatment

for Amblyopia

Sites in Fort Worth +12 more locations

Sponsor: Luminopia

Sex: All·Age: All ages

Code: NCT06429280·Recruiting·Listed May 2024

Apply to this trial

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

for Hypochondroplasia

Sites in Fort Worth +15 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: Up to 15

Code: NCT06212947·Recruiting·Listed Jan 2024

Apply to this trial

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

for Acute Kidney Injury

Sites in Fort Worth, Dallas +13 more locations

Sponsor: SeaStar Medical

Sex: All·Age: Up to 22

Code: NCT06517810·Recruiting·Listed Jul 2024

Apply to this trial

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

for Hyperphosphatemia

Sites in Fort Worth, Dallas +17 more locations

Sponsor: Alebund Pharmaceuticals

Sex: All·Age: 12+

Code: NCT06933472·Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

for Endometrial Cancer

Sites in Fort Worth, Austin +17 more locations

Sponsor: Kartos Therapeutics, Inc.

Sex: Female·Age: 18+

Code: NCT05797831·Phase 2, Phase 3·Recruiting·Listed Apr 2023

Apply to this trial

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for Colorectal Cancer

Sites in Fort Worth +5 more locations

Sponsor: Verastem, Inc.

Sex: All·Age: 18+

Code: NCT07659795·Phase 2·Recruiting·Listed Jun 22, 2026

Apply to this trial

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

for Advanced Malignancies

Sites in Fort Worth, Irving +4 more locations

Sponsor: PharmaMar

Sex: All·Age: 18+

Code: NCT07644039·Phase 1, Phase 2·Recruiting·Listed Jun 12, 2026

Apply to this trial

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

for Lymphoblastic Lymphoma

Sites in Fort Worth, Houston +3 more locations

Sponsor: Allterum Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT07586618·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for Solid Tumor

Sites in Fort Worth +2 more locations

Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07517198·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Sites in Fort Worth +1 more location

Sponsor: iLeukon Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07452224·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Study of ALK-001 on the Progression of Stargardt Disease

for Stargardt Disease

Sites in Fort Worth, Dallas +3 more locations

Sponsor: Alkeus Pharmaceuticals, Inc.

Sex: All·Age: 8 - 45

Code: NCT07419334·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

for Chronic Lymphocytic Leukemia

Sites in Fort Worth, Kyle +7 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07218341·Phase 4·Recruiting·Listed Oct 2025

Apply to this trial

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for Solid Tumours

Drug: BMS-986517

Sites in Fort Worth, San Antonio +7 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07160725·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

AERA Pediatrics Registry

for Dysfunction of Eustachian Tube

Sites in Fort Worth, Houston +7 more locations

Sponsor: Integra LifeSciences Corporation

Sex: All·Age: Up to 18

Code: NCT07071298·Recruiting·Listed Jul 2025

Apply to this trial

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

for Congenital Adrenal Hyperplasia

Sites in Fort Worth +8 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 1 - 17

Code: NCT07159841·Phase 2, Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

First In Human Study of CX-2051 in Advanced Solid Tumors

for Solid Tumor, Adult

Sites in Fort Worth, San Antonio +6 more locations

Sponsor: CytomX Therapeutics

Sex: All·Age: 18+

Code: NCT06265688·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

for Age-Related Macular Degeneration

Sites in Fort Worth, Tyler +3 more locations

Sponsor: i-Lumen Scientific AUS PTY LTD

Sex: All·Age: 60+

Code: NCT06662162·Recruiting·Listed Oct 2024

Apply to this trial

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

for Ovarian Cancer Recurrent

Sites in Fort Worth +7 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06843447·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial